<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="929">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 27, 2015</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00781196</url>
  </required_header>
  <id_info>
    <org_study_id>PIGO</org_study_id>
    <nct_id>NCT00781196</nct_id>
  </id_info>
  <brief_title>Folic Acid Supplementation in Phenytoin Induced Gingival Overgrowth</brief_title>
  <acronym>PIGO</acronym>
  <official_title>Effect of Low Dose Oral Folic Acid Supplementation on Phenytoin Induced Gingival Overgrowth: A Randomized Double Blind Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>All India Institute of Medical Sciences, New Delhi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>All India Institute of Medical Sciences, New Delhi</source>
  <oversight_info>
    <authority>India: Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Phenytoin, a common anti-seizure drug, leads to cosmetically unacceptable side effect of
      gingival overgrowth in a significant number of patients. There is some evidence of
      therapeutic effect of folic acid in cases of established phenytoin induced gingival
      overgrowth. In this study, the aim is to study the prospective preventive effect of low dose
      oral folic acid supplementation on phenytoin induced gingival overgrowth in epileptic
      children.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Occurrence of any grade of overgrowth in 2 groups after 6 mo of phenytoin therapy</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occurrence of grade &gt; 2 hyperplasia at the end of 6 mo</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to occurrence of grade &gt; 2 overgrowth</measure>
    <time_frame>open</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between following and occurrence of grade &gt; 2 overgrowth *phenytoin dose (in mg/kg/d) *serum phenytoin levels *plaque index</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Gingival Overgrowth</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral folic acid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>folic acid</intervention_name>
    <description>capsule 0.5 mg once a day</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>capsule, once a day</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: 6-15 yr

          -  Started on phenytoin within 1 mo of enrollment

        Exclusion Criteria:

          -  Not willing to participate

          -  On other folic acid antagonists e.g. anti-neoplastic drugs for &gt;/= 2 wks during last
             3 months

          -  Pre-existing gingival over-growth due to other cause
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>All India Institute of Medical Sciences</name>
      <address>
        <city>New Delhi</city>
        <state>Delhi</state>
        <zip>110029</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <lastchanged_date>August 3, 2009</lastchanged_date>
  <firstreceived_date>October 27, 2008</firstreceived_date>
  <responsible_party>
    <name_title>Ravindra Arya</name_title>
    <organization>All India Institute of Medical Sciences, New Delhi</organization>
  </responsible_party>
  <keyword>phenytoin</keyword>
  <keyword>gum hyperplasia</keyword>
  <keyword>phenytoin induced gingival overgrowth</keyword>
  <keyword>plaque index</keyword>
  <keyword>gingival overgrowth grade</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Gingival Overgrowth</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Phenytoin</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
